Back to Search
Start Over
Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente
- Source :
- Nutrition & Diabetes, 8:24. Nature Publishing Group, Nutrition & Diabetes, Nutrition & Diabetes, Vol 8, Iss 1, Pp 1-10 (2018), Nutrition & Diabetes, 8(1):24. Nature Publishing Group
- Publication Year :
- 2018
-
Abstract
- Background/Objectives Lowering low-density lipoprotein cholesterol (LDLc) in type 2 diabetes mellitus is of paramount importance in preventing cardiovascular disease. However, treatment targets for LDLc are often not reached. We studied the prevalence of LDLc target achievement in a real-life population of type 2 diabetes mellitus patients in secondary care, and investigated whether in those not on target, there is room for intensifying pharmacological and lifestyle management according to current treatment guidelines. Subjects/Methods We performed a cross-sectional analysis in the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT-1; n = 450, age 63 ± 9 years, 58% men, diabetes duration 11 (7–18) years). At baseline, we determined plasma LDLc concentration, pharmacological treatment (i.e., statin use), and lifestyle (physical activity and dietary intake). Patients were divided according to LDLc 2.5 mmol/l. Dietary intake was collected from a validated Food Frequency Questionnaire (177 items) and we determined guideline adherence for different food groups. Physical activity was assessed with the Short Questionnaire to ASsess Health enhancing behavior. Results LDLc data were available in 428 type 2 diabetes mellitus patients. LDLc ≤ 2.5 mmol/l was achieved in 317 patients (76%). In total, 76% of patients used statins, in those with LDLc > 2.5 mmol/l, this was 44%. Adherence to lifestyle guidelines was not different between the LDLc groups and was as follows: body mass index 6%, physical activity 59%, vegetables 7%, fruit 28%, legumes 59%, nuts 14%, dairy 19%, fish 36%, tea 8%, fats 66%, red meat 12%, processed meat 2%, alcohol 71%, sweetened beverages 34%, and sodium 12%. Conclusions In type 2 diabetes mellitus patients in secondary health care, the target LDLc is achieved by three quarters of patients. Increasing statin treatment could be a first step to improve LDLc. In addition, there are ample opportunities for lifestyle management through increasing adherence to lifestyle guidelines.
- Subjects :
- Male
CHRONIC KIDNEY-DISEASE
STATIN THERAPY
MONOCLONAL-ANTIBODY
Endocrinology, Diabetes and Metabolism
030204 cardiovascular system & hematology
Food group
0302 clinical medicine
CARDIOVASCULAR RISK-FACTORS
030212 general & internal medicine
lcsh:RC620-627
2. Zero hunger
education.field_of_study
Middle Aged
RANDOMIZED CONTROLLED-TRIAL
C-REACTIVE PROTEIN
3. Good health
Lifestyle management
lcsh:Nutritional diseases. Deficiency diseases
Treatment Outcome
DENSITY-LIPOPROTEIN CHOLESTEROL
Cohort
Red meat
Female
medicine.medical_specialty
Population
Article
03 medical and health sciences
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Humans
education
Exercise
Life Style
Aged
Dyslipidemias
business.industry
ACUTE CORONARY SYNDROMES
Type 2 Diabetes Mellitus
Cholesterol, LDL
medicine.disease
Diet
Cross-Sectional Studies
Diabetes Mellitus, Type 2
CLINICAL-PRACTICE
Hydroxymethylglutaryl-CoA Reductase Inhibitors
business
PRIMARY PREVENTION
Body mass index
Subjects
Details
- Language :
- English
- ISSN :
- 20444052
- Volume :
- 8
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Nutrition & Diabetes
- Accession number :
- edsair.doi.dedup.....cca0219b2a04f2d3ca7f9dec005affa3
- Full Text :
- https://doi.org/10.1038/s41387-018-0028-y